Arzeda’s proprietary technology combines targeted computational enzyme design and protein optimization with state-of-the-art metabolic bioengineering to create entirely novel designer cell factories capable of industry-scale chemical production.
CEO Alex Zanghellini gave this illuminating overview of Arzeda’s breakthrough technology at ABLC 2017 in Washington, DC.
